Estimated reading time: 9 minutes
Table of contents
- Introduction
- What did Initiative 438 do?
- Who supported and opposed Initiative 437?
- Nebraska Initiative 438, Medical Marijuana Regulation Initiative (2024) Results
- Support and Opposition
- The Future of Cannabis in Nebraska
- Nebraska Initiative Measures 437 & 438 FAQs
- Additional Resources
- Free eBooks For Cannabis Business Success
- Latest Articles
Introduction
Nebraskans voted Tuesday, November 5th, 2024 to embrace legalizing and regulating medical cannabis. Multiple legislative efforts, including some led by one of the ballot sponsors, State Sen. Anna Wishart of Lincoln, had previously stalled, moving the fight to the ballot box.
Both Initiative Measures 437 and 438, to legalize and regulate medical cannabis, had a wide margin of support statewide. The measures came from the Nebraskans for Medical Marijuana campaign. This was the campaign’s third attempt to reach the ballot. For expert insights into the evolving regulatory landscape, many stakeholders have turned to a trusted Nebraska Cannabis Consultant.
Initiative Measure 437, the Nebraska Medical Cannabis Patient Protection Act, would set an allowable amount of medical cannabis at 5 ounces; exempt patients and caregivers from penalty for using or assisting someone else in using the cannabis; and require a written recommendation from a health care practitioner before prescription.
Initiative Measure 438, the Nebraska Medical Cannabis Regulation Act, would define cannabis; legalize possessing, manufacturing, distributing, delivering and dispensing cannabis for medical purposes; and create the Nebraska Medical Cannabis Commission to oversee the new law. For tailored guidance on the implications of these measures, consider speaking with our Nebraska Cannabis Consulting team.
What did Initiative 438 do?
The initiative enacted the Nebraska Medical Cannabis Regulation Act. The act legalized the possession, manufacture, distribution, delivery, and dispensing of marijuana for medical purposes. It established the Nebraska Medical Cannabis Commission to regulate and provide the necessary registration for the medical marijuana program.
The commission consisted of at least three members but no more than five. The three Nebraska Liquor Control Commission members served as ex officio members of the new commission. The governor appointed two additional members, subject to approval by the state legislature, to serve six-year terms on the commission. The commission was charged with establishing criteria and processes for registration no later than July 1, 2025.
Set to begin on October 1, 2025, the commission was required to start granting registration to applicants who met the established criteria. It had the authority to subpoena witnesses and records, inspect the operations of registered marijuana establishments, and impose fines for violations of rules and regulations.
Who supported and opposed Initiative 437?
Nebraskans for Medical Marijuana led the campaign in support of Initiatives 437 and 438. The committee reported over $1.5 million in contributions. The initiative was endorsed by State Sen. Anna Wishart (D), Nebraska Families 4 Medical Cannabis, and New Venture Fund. Nebraskans for Medical Marijuana campaign said, “The facts are clear: The sky does not fall when patients have safe, legal access to medical cannabis. Thirty-six states have implemented these kinds of programs, and no state has ever repealed their medical cannabis law. Opponents of medical cannabis do not have the facts on their side, so they resort to scare tactics.”
Nebraska Initiative 438, Medical Marijuana Regulation Initiative (2024) Results
The Nebraska Medical Marijuana Regulation Initiative was on the ballot in Nebraska as an initiated state statute on November 5, 2024. The ballot measure was approved.
• A “yes” vote supported repealing penalties for the possession, manufacture, distribution, delivery, and dispensing of marijuana for medical purposes and establishing the Nebraska Medical Cannabis Commission to regulate the medical marijuana industry in the state.
• A “no” vote opposed repealing penalties for the possession, manufacture, distribution, delivery, and dispensing of marijuana for medical purposes and establishing the Nebraska Medical Cannabis Commission to regulate the medical marijuana industry in the state.
| Result of Nebraska Initiative 438 | Votes | Percentage | |
| Yes | 600,481 | 67.29% | |
| No | 291,867 | 32.71% | |
Support and Opposition
Supporters
Officials
• State Sen. Anna Wishart (D)
Former Officials
• Former State Sen. Adam Morfeld (D)
Organizations
• Nebraska Families 4 Medical Cannabis
• New Venture Fund
Arguments
• State Sen. Anna Wishart (R-27): “This is why we fight so hard for safe access to medical cannabis. Colton has life-threatening seizures and has been told by medical experts that cannabis could save his life. His mom, Crista, has been leading our effort and fighting for her son for seven-plus years. This must be the year we succeed and let Nebraskans vote on this issue in November.”
• Nebraskans for Medical Marijuana campaign: “The facts are clear: The sky does not fall when patients have safe, legal access to medical cannabis. Thirty-six states have implemented these kinds of programs, and no state has ever repealed their medical cannabis law. Opponents of medical cannabis do not have the facts on their side, so they resort to scare tactics.”
Opponents
Former Officials
• Former State Sen. John Kuehn
The Future of Cannabis in Nebraska
Nebraska Initiative Measures 437 and 438 represent a transformative step toward modernizing the state’s approach to cannabis policy. Initiative 437 focuses on decriminalizing the possession of small amounts of cannabis, replacing criminal penalties with civil fines and reducing the burden on the justice system.
In contrast, Initiative 438 aims to establish a regulated framework for cannabis production, distribution, and consumption, with an emphasis on social equity by prioritizing licenses for communities historically affected by stringent enforcement.
Together, these measures seek to promote public health, drive economic growth through a legitimate market, and reinvest generated revenue back into community programs, setting the stage for a more progressive and just cannabis regulatory environment in Nebraska. Our Nebraska Cannabis Consultants can help businesses and communities navigate this new landscape effectively.
Nebraska Initiative Measures 437 & 438 FAQs
From securing municipal approvals, and applying for and receiving a cannabis license, to developing SOPs and facility designs, there are significant considerations involved. Our Nebraska cannabis consultants can provide end-to-end support to help you launch and sustain your cannabis business.
There is no list of qualifying conditions. Healthcare practitioners can certify any patient for whom “in the healthcare practitioner’s professional judgment, the potential benefits of cannabis outweigh the potential harms for the alleviation of a patient’s medical condition, its symptoms, or side effects of the condition’s treatment.”
An adult patient must have a written recommendation from a healthcare practitioner stating that, in the practitioner’s professional judgment, “the potential benefits of cannabis outweigh the potential harms for the alleviation of a patient’s medical condition, its symptoms, or side effects of the condition’s treatment.” The declaration must be signed and dated by the practitioner.
Minor patients must also have a signed and dated written recommendation from a healthcare practitioner, with the same requirements as adult patients. They also must have written permission from a parent or legal guardian who has authority to make their healthcare decisions.
Any physician (MD), osteopathic physician (DO), physician assistant, or nurse practitioner who is licensed under Nebraska’s Uniform Credentialing Act or who is licensed in any state and practicing in compliance with the Uniform Credentialing Act.
No.
Penalties are removed for patients who possess, use, and acquire medical cannabis and for caregivers who assist them by possessing and acquiring cannabis on their behalf. The law does not specify that the cannabis must be acquired from any specific source. Medical cannabis businesses will likely not open in Nebraska until 2026. However, cannabis is legal for all adults 21 and older in two of Nebraska’s border states — Colorado and Missouri.
A new Nebraska Medical Cannabis Commission will license private businesses to possess, manufacture, distribute, deliver, and dispense medical cannabis. It can issue different types of licenses for different activities.
The first three members of the Nebraska Medical Cannabis Commission will be the three members of the Nebraska Liquor Control Commission. The governor can appoint two more members, which would need confirmation from the legislature. The commission will also have staff.
It will promulgate and enforce reasonable rules for those businesses and conduct inspections.
Yes, but the Legislature can only “amend, repeal, modify, or impair” a voter-approved ballot initiative if two-thirds of its members or more vote to do so.
Catalyst BC consultants offer cannabis business planning, application writing, facility design, municipal approval, operational guidance, and cannabis M&A advisory services to help you achieve your goals in the Nebraska cannabis industry.
Additional Resources
Free eBooks For Cannabis Business Success
Latest Articles
- Virginia Cannabis Cultivation License (2027): The Tiered System Explained
For operators whose strength is growing cannabis, Virginia’s emerging adult-use market presents a significant opportunity – and a cultivation license is the gateway to it. The June 2026 framework authorizes the Virginia Cannabis Control Authority (CCA) to begin accepting license applications on or after February 1, 2027 and issuing licenses on or after May 1, 2027. It also establishes five cultivation tiers with maximum canopies ranging from 5,000 to 35,000 square feet. - Virginia Impact Cannabis License (2027): Social Equity & the Equity Business Loan Fund
Virginia’s adult-use cannabis framework creates a meaningful pathway for applicants from communities and backgrounds affected by cannabis prohibition and enforcement. The law does not create a separate, stand-alone impact license. Instead, it creates an impact-licensee designation that qualifying applicants may pursue alongside an underlying marijuana establishment license, such as retail, cultivation, processing, microbusiness, transportation, delivery, or testing. - Virginia Cannabis Microbusiness License (2027): Eligibility & the Two-Location Model
This guide explains the initial eligibility pathways for the licenses the CCA may issue by May 1, 2027, the difference between a microbusiness license and an impact designation, the indoor and outdoor cultivation limits, the precise rules governing two locations, and the financial, security, and operational readiness standards applicants should prepare to demonstrate. Several implementation details – including fees and the specific combination of privileges the CCA will authorize – still depend on forthcoming regulations. - Virginia Dual-Use Cannabis Conversion (2027): The $10M Medical-to-Adult-Use Pathway
For Virginia’s existing medical cannabis operators, the 2026 retail framework created a distinct and high-stakes transition: pharmaceutical processors may apply for verification to exercise dual-use privileges and serve both registered medical patients and adult-use customers. The pathway covers the processor and its permitted cannabis dispensing facilities, and it carries a one-time $10 million fee, a required medical cannabis program preservation plan, an impact-licensee business accelerator commitment, and a firm May 1, 2027 payment or installment-plan deadline. - Virginia Cannabis Facility Design & Build-Out for the 2027 Market
This guide covers the major considerations involved in planning and building a Virginia cannabis facility, with a focus on retail and cultivation operations and additional considerations relevant to processors and microbusinesses. It is written from the build side of the business, because that is where many otherwise-strong applicants stumble: they underestimate utility needs, local approvals, security infrastructure, commissioning, and the time required to convert a site into an inspection-ready operation. - How to Open a Dispensary in Virginia: The 2027 Retail Store License Guide
If you’ve been waiting for the chance to open a cannabis dispensary in Virginia, that chance is now real. With the General Assembly’s June 2026 approval of a regulated retail framework, Virginia is on track to begin adult-use sales on July 1, 2027, and the Cannabis Control Authority (CCA) is expected to open license applications on February 1, 2027.